Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Brenda F. Ginos"'
Autor:
Jennifer Huberty, Ryan Eckert, Krisstina Gowin, Jules Mitchell, Amylou C. Dueck, Brenda F. Ginos, Linda Larkey, Ruben Mesa
Publikováno v:
Haematologica, Vol 102, Iss 10 (2017)
Externí odkaz:
https://doaj.org/article/2cad7c4e502b4435a7a2051cac265287
Autor:
Katharine, Price, Kathryn M, Van Abel, Eric J, Moore, Samir H, Patel, Michael L, Hinni, Ashish V, Chintakuntlawar, Darlene, Graner, Michelle, Neben-Wittich, Yolanda I, Garces, Daniel L, Price, Jeffrey R, Janus, Nathan R, Foster, Brenda F, Ginos, Robert L, Foote, Daniel, Ma
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 114:256-265
Patients with human papillomavirus oropharyngeal cancer are highly curable but risk significant long-term toxic effects with standard therapy. This study investigated a de-escalation strategy of decreased adjuvant radiation therapy and chemotherapy a
Autor:
Victoria Susana Blinder, Allison Mary Deal, Brenda F. Ginos, Jennifer Jansen, Amylou C. Dueck, Gina L. Mazza, Sydney Henson, Philip M Carr, Lauren J. Rogak, Anna Weiss, Anna Rapperport, Patricia Spears, Francesca Gany, Deborah Schrag, Ethan Basch
Publikováno v:
Journal of Clinical Oncology. 40:180-180
180 Background: Financial toxicity affects 20% of cancer survivors and is associated with decreased treatment adherence and poor clinical outcomes. No large-scale programs have been implemented to mitigate financial toxicity among patients undergoing
Autor:
Kostandinos Sideras, David W Hillman, Karthik Giridhar, Brenda F Ginos, Richard C Tenglin, Heshan Liu, Beiyun Chen, Winston Tan, Gerald G Gross, Rex B Mowat, Amylou C Dueck, Edith A Perez, Alvaro Moreno-Aspitia
Publikováno v:
The oncologist.
Background Anthracycline use in metastatic breast cancer (MBC) is hindered by cumulative exposure limits and risk of cardiotoxicity. Pixantrone, a novel aza-anthracenedione with structural similarities to mitoxantrone and anthracyclines, is theorized
Autor:
Joselle Cook, Kah-Whye Peng, Susan Geyer, Amylou C. Dueck, Brenda F. Ginos, Marissa Giers, Nandakumar Packiriswamy, Lianwen Zhang, Beth Brunton, Mrnal S. Patnaik, Thomas Witzig, Francis Buadi, Angela Dispenzieri, Morie Gertz, Ronald Go, Suzanne Hayman, John Lust, David Dingli, S Vincent Rajkumar, Nelson Leung, Rahma Warsame, Wilson Gonsalves, Taxiarchis Kourelis, Eli Muchtar, Leif Bergsagel, Stephen Broski, Prashant Kapoor, Robert Kyle, Yi Lin, Mustagueem Siddiqui, Amie Fonder, Miriam Hobbs, Lisa Hwa, Shaji Kumar, Stephen Russell, Martha Lacy
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S248
Autor:
Martha Q. Lacy, Kah-Whye Peng, Stephen J. Russell, Amylou C. Dueck, Mrinal M. Patnaik, Thomas E. Witzig, Brenda F Ginos, Francis K. Buadi, Angela Dispenzieri, Morie A. Gertz, Ronald S. Go, Suzanne R. Hayman, John A. Lust, David Dingli, S. Vincent Rajkumar, Nelson Leung, Rahma Warsame, Wilson I Gonsalves, Taxiarchis Kourelis, Eli Muchtar, Stephen Broski, Robert C Murphy, Prashant Kapoor, Robert A. Kyle, Steven Zeldenrust, Aref Al-Kali, Mark R. Litzow, Shruthi Naik, Mark J Federspiel, Shaji K. Kumar
Publikováno v:
Blood. 132:3268-3268
Background: We previously reported successful treatment of myeloma with an oncolytic virus, MMV-NIS. Preexisting immunity against measles made use of that virus unsatisfactory. The Indiana strain of Vesicular Stomatitis Viruses (VSV) are being develo